The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

被引：0
|
作者：
Sollelis, E. [1 ,2 ,3 ]
Quinard, R. Minet [4 ]
Bouguen, G. [5 ]
Goutte, M. [1 ,2 ,3 ]
Goutorbe, F. [1 ,6 ]
Bouvier, D. [4 ]
Pereira, B. [7 ]
Bommelaer, G. [1 ,2 ,3 ]
Buisson, A. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Estaing, Gastroenterol Dept, Clermont Ferrand, France
[2] Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France
[3] USC INRA 2018, Microbes Intestine Inflammat & Susceptibil Host, Clermont Ferrand, France
[4] Univ Hosp G Montpied, Biochem Lab, Clermont Ferrand, France
[5] Univ Hosp, Rennes, France
[6] Hosp Bayonne, Gastroenterol Dept, Bayonne, France
[7] Univ Hosp, Biostat Unit, DRCI Clermont Ferrand, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P504
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [31] Increased Risk of Surgery After Attenuation of Anti-TNFα Therapy for Crohn's Disease
    Bosworth, Brian P.
    Lebwohl, Benjamin
    Taunk, Raja
    Green, Nicole
    Lakehomer, Harrison
    Iroku, Ugonna
    Swaminath, Arun
    Milsom, Jeffrey W.
    Michelassi, Fabrizio
    Scherl, Ellen J.
    GASTROENTEROLOGY, 2010, 138 (05) : S856 - S856
  • [32] REASSESSMENT OF CROHN'S DISEASE TREATED WITH 12 MONTHS OF ANTI-TNF THERAPY: A TERTIARY CENTRE EXPERIENCE
    Dart, R.
    Griffin, N.
    Taylor, K.
    Duncan, J.
    Sastrillo, M.
    Anderson, S.
    Sanderson, J.
    Irving, P. M.
    GUT, 2012, 61 : A397 - A397
  • [33] Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease
    Buisson, Anthony
    Hordonneau, Constance
    Goutte, Marion
    Scanzi, Julien
    Goutorbe, Felix
    Klotz, Thomas
    Boyer, Louis
    Pereira, Bruno
    Bommelaer, Gilles
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (03) : 260 - 266
  • [34] Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease
    Lucca, F. A.
    Malaguti, C.
    Cabalzar, A. L.
    Chebli, L. A.
    Ribeiro, T. C. R.
    Gaburri, P. D.
    Chebli, J. M. F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S344 - S344
  • [35] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [36] Continuation or Switch to Another Anti-TNFα After Intestinal Resection in Crohn's Disease Patients Previously Exposed to Anti-TNFα?
    Collins, Michael
    Sarter, Helene
    Gower-Rousseau, Corinne
    Nachury, Maria
    Libier, Louise
    Cortot, Antoine
    Zerbib, Philippe
    Colombel, Jean-Frederic
    Desreumaux, Pierre
    Blanc, Pierre
    de Chambrun, Guillaume Pineton
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
  • [37] WEIGHT ADJUSTED ANTI-TNF THERAPY FAVOURS OBESE PATIENTS WITH CROHN'S DISEASE
    Bhalme, M.
    Sharma, A.
    Keld, R.
    Makin, A.
    Willert, R.
    Campbell, S.
    GUT, 2012, 61 : A228 - A228
  • [38] Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon
    O'Donnell, Sarah
    Chawla, Tanya P.
    Nguyen, Geoffrey C.
    Silverberg, Mark S.
    Steinhart, A. Hillary
    Croitoru, Kenneth
    GASTROENTEROLOGY, 2015, 148 (04) : S459 - S459
  • [39] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
  • [40] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    GUT, 2015, 64 (02) : 233 - 242
12345